The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 297, Issue 5, 2009, Pages

  Im, Eunok ^a   Choi, Yoon Jeong ^a   Kim, Cho Hee ^a   Fiocchi, Claudio ^b   Pothoulakis, Charalabos ^a   Rhee, Sang Hoon ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MRL 1240 ^*  (United States)

Author keywords

CXCR; Inflammatory bowel diseases; Wound healing

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; ACTIN; ANGIOGENIC FACTOR; CD31 ANTIGEN; CELASTROL; CHEMOKINE RECEPTOR CXCR2; DEXTRAN SULFATE; F ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; NEUTRALIZING ANTIBODY; PROBIOTIC AGENT; RNA; SN 50;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACILLUS; BACILLUS POLYFERMENTICUS; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL STRAIN; CELL STRAIN NCM 460; COLITIS; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; INTESTINE MUCOSA; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM HEMORRHAGE; WEIGHT GAIN; WOUND HEALING;

ANIMALS; BACILLUS; CAPILLARY PERMEABILITY; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLITIS, ULCERATIVE; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; INTESTINES; MALE; MICE; MICE, INBRED STRAINS; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; PHENYLUREA COMPOUNDS; PHOSPHORYLATION; PROBIOTICS; RECEPTORS, INTERLEUKIN-8B; STRESS FIBERS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 72249088233     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00204.2009     Document Type: Article

References (62)

1. Ahuja SK, Ozcelik T, Milatovitch A, Francke U, Murphy PM. Molecular evolution of the human interleukin-8 receptor gene cluster. Nat Genet 2: 31-36, 1992.
2. Ajuebor MN, Zagorski J, Kunkel SL, Strieter RM, Hogaboam CM. Contrasting roles for CXCR2 during experimental colitis. Exp Mol Pathol 76: 1-8, 2004. (Pubitemid 38096312)
3. Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM. CXC chemokines in angiogenesis. J Leukoc Biol 68: 1-8, 2000.
4. Bento AF, Leite DF, Claudino RF, Hara DB, Leal PC, Calixto JB. The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J Leukoc Biol 84: 1213-1221, 2008.
5. Biffl WL, Moore EE, Moore FA, Carl VS, Franciose RJ, Banerjee A. Interleukin-8 increases endothelial permeability independent of neutrophils. J Trauma 39: 98-102; discussion 102-103, 1995.
6. Binion DG, West GA, Ina K, Ziats NP, Emancipator SN, Fiocchi C. Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology 112: 1895-1907, 1997.
7. Bishop A. Role of oxygen in wound healing. J Wound Care 17: 399-402, 2008.
8. Bousvaros A, Zurakowski D, Fishman SJ, Keough K, Law T, Sun C, Leichtner AM. Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing. Dig Dis Sci 42: 378-386, 1997. (Pubitemid 27112987)
9. Buanne P, Di Carlo E, Caputi L, Brandolini L, Mosca M, Cattani F, Pellegrini L, Biordi L, Coletti G, Sorrentino C, Fedele G, Colotta F, Melillo G, Bertini R. Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J Leukoc Biol 82: 1239-1246, 2007. (Pubitemid 350133522)
10. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 438: 932-936, 2005.
11. Cho CH, Sung HK, Kim KT, Cheon HG, Oh GT, Hong HJ, Yoo OJ, Koh GY. COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci USA 103: 4946-4951, 2006.
12. Danese S, Sans M, de la Motte C, Graziani C, West G, Phillips MH, Pola R, Rutella S, Willis J, Gasbarrini A, Fiocchi C. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130: 2060-2073, 2006. (Pubitemid 43816964)
13. Danese S, Sans M, Spencer DM, Beck I, Doñate F, Plunkett ML, de la Motte C, Redline R, Shaw DE, Levine AD, Mazar AP, Fiocchi C. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut 56: 855-862, 2007. (Pubitemid 46854204)
14. Dhanabal M, Wu F, Alvarez E, McQueeney KD, Jeffers M, MacDougall J, Boldog FL, Hackett C, Shenoy S, Khramtsov N, Weiner J, Lichenstein HS, LaRochelle WJ. Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis. Cancer Biol Ther 4: 659-668, 2005. (Pubitemid 41351204)
15. Farooq SM, Stillie R, Svensson M, Svanborg C, Strieter RM, Stadnyk AW. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis. J Pharmacol Exp Ther 329: 123-129, 2009.
16. Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 10: 286-299, 2004. (Pubitemid 38618261)
17. Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 438: 960-966, 2005.
18. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 69: 513-521, 2001.
19. Giorgini S, Trisciuoglio D, Gabellini C, Desideri M, Castellini L, Colarossi C, Zangemeister-Wittke U, Zupi G, Del Bufalo D. Modulation of bcl-xL in tumor cells regulates angiogenesis through CXCL8 expression. Mol Cancer Res 5: 761-771, 2007. (Pubitemid 47294804)
20. Gong C, Stoletov KV, Terman BI. VEGF treatment induces signaling pathways that regulate both actin polymerization and depolymerization. Angiogenesis 7: 313-321, 2004. (Pubitemid 40767933)
21. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21: 1743-1753, 2002. (Pubitemid 34614630)
22. Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann RR, Wiedenmann B, Dignass AU, Sturm A. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun 74: 4075-4082, 2006.
23. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351: 2805-2816, 2004.
24. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 361: 512-519, 2003.
25. Halper J, Leshin LS, Lewis SJ, Li WI. Wound healing and angiogenic properties of supernatants from Lactobacillus cultures. Exp Biol Med (Maywood) 228: 1329-1337, 2003. (Pubitemid 37549237)
26. Hatoum OA, Binion DG, Otterson MF, Gutterman DD. Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 125: 58-69, 2003.
27. Hatoum OA, Heidemann J, Binion DG. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease. Ann NY Acad Sci 1072: 78-97, 2006. (Pubitemid 44448445)
28. Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, Otterson MF, Ota DM, Lugering N, Domschke W, Binion DG. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 278: 8508-8515, 2003. (Pubitemid 36800603)
29. Hu DE, Hori Y, Fan TP. Interleukin-8 stimulates angiogenesis in rats. Inflammation 17: 135-143, 1993.
30. Huebner ES, Surawicz CM. Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol Clin North Am 35: 355-365, 2006. (Pubitemid 44118667)
31. Im E, Venkatakrishnan A, Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell 16: 3488-3500, 2005. (Pubitemid 41077063)
32. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 11: 457-465, 1997.
33. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 96: 822-828, 2001. (Pubitemid 32240738)
34. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436, 2006. (Pubitemid 44050137)
35. Kim HS, Park H, Cho IY, Paik HD, Park E. Dietary supplementation of probiotic Bacillus polyfermenticus, Bispan strain, modulates natural killer cell and T cell subset populations and immunoglobulin G levels in human subjects. J Med Food 9: 321-327, 2006. (Pubitemid 44850714)
36. Kirsner RS, Eaglstein WH. The wound healing process. Dermatol Clin 11: 629-640, 1993.
37. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, Yasui W, Ohmoto Y, Kajiyama G, Fidler IJ, Tahara E. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 152: 93-100, 1998. (Pubitemid 28028050)
38. Konno S, Iizuka M, Yukawa M, Sasaki K, Sato A, Horie Y, Nanjo H, Fukushima T, Watanabe S. Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease. J Gastroenterol 39: 931-939, 2004. (Pubitemid 39490169)
39. Lam EK, Yu L, Wong HP, Wu WK, Shin VY, Tai EK, So WH, Woo PC, Cho CH. Probiotic Lactobacillus rhamnosus GG enhances gastric ulcer healing in rats. Eur J Pharmacol 565: 171-179, 2007. (Pubitemid 46805089)
40. Lee KH, Jun KD, Kim WS, Paik HD. Partial characterization of polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus. Lett Appl Microbiol 32: 146-151, 2001. (Pubitemid 32223507)
41. Lee NK, Park JS, Park E, Paik HD. Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine. Lett Appl Microbiol 44: 274-278, 2007. (Pubitemid 46277016)
42. Lee PC, Salyapongse AN, Bragdon GA, Shears LL 2nd, Watkins SC, Edington HD, Billiar TR. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol Heart Circ Physiol 277: H1600-H1608, 1999.
43. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87: 565-576, 1996. (Pubitemid 26374329)
44. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
45. Majno G. Chronic inflammation: links with angiogenesis and wound healing. Am J Pathol 153: 1035-1039, 1998. (Pubitemid 28465827)
46. Martins-Green M, Bissell MJ. Localization of 9E3/CEF-4 in avian tissues: expression is absent in Rous sarcoma virus-induced tumors but is stimulated by injury. J Cell Biol 110: 581-595, 1990. (Pubitemid 20088926)
47. Park E, Jeon GI, Park JS, Paik HD. A probiotic strain of Bacillus polyfermenticus reduces DMH induced precancerous lesions in F344 male rat. Biol Pharm Bull 30: 569-574, 2007. (Pubitemid 46355951)
48. Petreaca ML, Yao M, Liu Y, Defea K, Martins-Green M. Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability. Mol Biol Cell 18: 5014-5023, 2007. (Pubitemid 350246701)
49. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16: 658-672, 2003. (Pubitemid 37296554)
50. Rhee SH, Im E, Pothoulakis C. Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer. Gastroenterology 135: 518-528, 2008.
51. Rhee SH, Im E, Riegler M, Kokkotou E, O'Brien M, Pothoulakis C. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci USA 102: 13610-13615, 2005. (Pubitemid 41420896)
52. Rhee SH, Jones BW, Toshchakov V, Vogel SN, Fenton MJ. Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages. J Biol Chem 278: 22506-22512, 2003. (Pubitemid 36830305)
53. Rhee SH, Keates AC, Moyer MP, Pothoulakis C. MEK is a key modulator for TLR5-induced interleukin-8 and MIP3alpha gene expression in non-transformed human colonic epithelial cells. J Biol Chem 279: 25179-25188, 2004. (Pubitemid 38756768)
54. Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, Wasserman K, Oppenheim JJ. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 14: 2055-2064, 2000. (Pubitemid 30747261)
55. Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 21: 44-50, 2005.
56. Schuh JM, Blease K, Hogaboam CM. CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J Immunol 168: 1447-1456, 2002. (Pubitemid 34094518)
57. Shea-Donohue T, Thomas K, Cody MJ, Aiping Z, DeTolla LJ, Kopydlowski KM, Fukata M, Lira SA, Vogel SN. Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun 14: 117-124, 2008.
58. Spalinger J, Patriquin H, Miron MC, Marx G, Herzog D, Dubois J, Dubinsky M, Seidman EG. Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology 217: 787-791, 2000. (Pubitemid 30952193)
59. Stegmaier JC, Kirchhoff C, Bogner V, Matz M, Kanz KG, Mutschler W, Biberthaler P. Dynamics of neutrophilic NF-kB translocation in relation to IL-8 mRNA expression after major trauma. Inflamm Res 57: 547-554, 2008.
60. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan SY, Roczniak S, and Shanafelt AB. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 270: 27348-27357, 1995.
61. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA, Pounder RE. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 2: 1057-1062, 1989. (Pubitemid 19264073)
62. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2: 541-546, 2007. (Pubitemid 47040018)